ONVO Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	152 966
Vidutinė apimtis	1.06M
Rinkos kapitalizacija	14.03M
EPS	$0 ( 2024-02-08 )
Kita pelno data	( $-0.420 ) 2024-07-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.500
ATR14	$0.00500 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-17	Stern Adam K	Buy	19 607	Common Stock
2023-11-17	Milhous Alison Tjosvold	Buy	19 607	Common Stock
2023-11-17	Cohen Douglas Jay	Buy	19 607	Common Stock
2023-11-17	Murphy Keith	Buy	19 607	Common Stock
2023-11-17	Gobel David	Buy	19 607	Common Stock

INSIDER POWER
80.75
Last 90 transactions
Buy: 3 116 580 \| Sell: 414 691

Tūris Koreliacija

Ilgas: 0.02 (neutral)

Trumpas: -0.73 (moderate negative)

Signal:(46.812) Neutral

Organovo Holdings Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Organovo Holdings Inc Koreliacija - Valiuta/Žaliavos

0.41
( neutral )

-0.46
( neutral )

0.00
( neutral )

-0.57
( weak negative )

0.00
( neutral )

-0.56
( weak negative )

Organovo Holdings Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$370 000
Bruto pelnas:	$77 000.00 (20.81 %)
EPS:	$-1.980

FY	2022
Pajamos:	$370 000
Bruto pelnas:	$77 000.00 (20.81 %)
EPS:	$-1.980

FY	2022
Pajamos:	$1.50M
Bruto pelnas:	$1.50M (100.00 %)
EPS:	$-1.320

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-2.44

Financial Reports:

No articles found.

Organovo Holdings Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Organovo Holdings Inc

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.